Expansion and Wider Distribution of High-Value-Added Products Using Stem Cells and Other Ingredients
First written in FY2019. 9 of 23 entries say "Advanced", first in FY2020-Q1. Latest entry: FY2026-H1.
0 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「Eyelash care salon sales are currently performing steadily. The company is also actively considering the planning and production of new products and working to diversify its service offerings.」
The policy of pursuing product planning and production and diversifying service offerings has continued following the shift to the wellness business. - FY2025RestatedAnnual report
「In the eyelash care business, the company is establishing an optimal salon network for the current operating environment by reviewing the number of stores during the previous consolidated fiscal year. It is also seeking to promote overseas sales in the merchandise segment.」
The policy of expanding products and distribution by promoting overseas merchandise sales while optimizing the scale of the stores remains in place. - FY2025-H1RestatedAnnual report
「Following the store reductions implemented in the previous consolidated fiscal year, the company has established an optimal store network for the current operating environment and is targeting a return to profitability in the current fiscal year by strengthening its strategy to expand merchandise sales.」
The company has reaffirmed its policy of strengthening merchandise sales in the eyelash care business and returning to profitability in the current fiscal year after optimizing the scale of its stores. - FY2025-Q1Continued strengthening of merchandise sales, revenue decline and target of returning to profitabilityAnnual report
「The company is seeking to balance income and expenses at a business scale suited to the current operating environment, including reducing the number of unprofitable stores by 1 during the previous fiscal year and strengthening overseas sales of merchandise.」
While continuing to strengthen overseas merchandise sales, the company is adjusting the scale of its business to achieve balance between income and expenses. Revenue from the eyelash care business, including merchandise, was ¥42 million, down 16.3% year on year, and the company is targeting a return to profitability during the current fiscal year. - FY2024WorsenedAnnual report
「In the merchandise segment, customer spending per transaction declined due to continued entry by competitors, an increase in low-priced products and a decline in the number of purchases by existing customers, resulting in performance below plan. As a result, revenue was ¥179 million, down 13.0% year on year, and the segment loss (operating loss) was ¥21 million, compared with an operating loss of ¥54 million in the previous fiscal year, narrowing the loss by ¥32 million from the previous consolidated fiscal year.」
Despite measures to expand high-value-added products and distribution, the entry of competitors, an increase in low-priced products and a decline in purchases by existing customers reduced customer spending per transaction and merchandise segment sales, resulting in revenue 13.0% below the previous fiscal year. Meanwhile, the operating loss narrowed. - FY2024-Q2Updated sales measures and decline in merchandise salesAnnual report
「We have renewed the eyelash serum that supports aging care and has seen significant growth in shipment volume, positioned it as a key product at salons and on our own website, and will accelerate further sales.」
While measures to accelerate sales through the renewal and elevation of eyelash serum as a key product were outlined, merchandise sales through the company’s website were 86% of the previous year due to lower sales per customer and the entry of lower-priced products. - FY2023SoftenedAnnual report
「In the product division, the effectiveness of social media advertising for the new eyelash serum product was weak, and the number of purchases by existing customers declined, resulting in performance below plan. Product-division sales for the current consolidated fiscal year declined to 89% of the previous fiscal year's level.」
Regarding measures to expand high-value-added products and merchandise, the effect of social media advertising for eyelash serums was weak and the number of purchases by existing customers also declined, resulting in merchandise sales of 89% of the previous fiscal year. - FY2023-Q3AdvancedAnnual report
「For product sales, we began subscription sales through our own website during the current third quarter of the consolidated fiscal year for the new eyelash serum launched during the second quarter of the consolidated fiscal year. In conjunction with this, we will run social media and native advertising, meaning advertisements displayed within content such as articles and news on media platforms, to improve product awareness and expand sales channels.」
For the new eyelash serum product, subscription sales have begun through the Company's own website, with progress toward increasing awareness and expanding sales channels through social media and native advertising. - FY2023-Q2AdvancedAnnual report
「A new eyelash serum product was completed in late August 2022, and we have just begun selling it. For now, the new product is sold only through our own website, but we plan to expand our sales channels and offer it on a subscription basis.」
Expansion of high-value-added products and cosmetics progressed with the completion and launch of a new eyelash serum product, and a plan was presented to expand sales channels and introduce subscription sales beyond sales through the Company's own website. - FY2023-Q1AdvancedAnnual report
「Demand for eyelash serum has increased as masks have become commonplace and attention has shifted toward the eye area, so we will focus on selling new eyelash serum products. In the product division, we held exhibitions as in the previous year and extended the period of simultaneous online sales compared with the previous year, resulting in sales of approximately 110% of the prior-year level.」
Against a backdrop of rising demand for eyelash serum, the Company strengthened sales of new products, and product-division sales reached approximately 110% of the previous year's level through exhibition participation and an extended online sales period. - FY2022SoftenedAnnual report
「The development and launch of new products scheduled for the current consolidated fiscal year were delayed, causing sales in the product division during the current consolidated fiscal year to decline to 79% of the prior-year period.」
As part of the product expansion measures, delays in developing and launching new products reduced product-division sales to 79% of the prior-year period. The launch of the new products has been pushed back to the following consolidated fiscal year. - FY2022-Q3AdvancedAnnual report
「For product sales, we will focus on developing packaging aligned with the SDGs, conduct tie-up promotions (advertising) with bloggers and others, and strengthen direct-to-consumer sales of cosmetics.」
Specific measures to expand sales of high-value-added products and cosmetics have been presented, including SDG-aligned packaging, tie-up advertising with bloggers and others, and direct-to-consumer sales of cosmetics. - FY2022-Q2RestatedAnnual report
「With respect to products, while developing products that reflect current trends, we will sell inventory overseas in response to changes in the market.」
The policy of expanding high-value-added products and other products has been reconfirmed through measures to develop products reflecting current trends and sell inventory overseas in response to market changes. - FY2022-Q1AdvancedAnnual report
「As sales of eyelash serum have increased significantly to 166% of the same period last year, we will focus on selling eyelash serum. In addition, following the conclusion of a contract with a new overseas retailer, we intend to focus on overseas transactions as well.」
Eyelash serum sales rose to 166% of the prior-year period, and contracts were concluded with new overseas retailers, indicating progress in expanding sales of high-value-added products and overseas distribution. - FY2021AdvancedAnnual report
「For product sales, while increasing the range of advertising formats, we will concentrate spending on advertising that has proven effective in seeking further expansion.」
Measures to expand sales of high-value-added products, cosmetics and other products have been made more specific through a broader range of advertising formats and concentrated budget allocation based on effectiveness measurements. - FY2021-Q3AdvancedAnnual report
「In fact, during the third quarter of the consolidated accounting period, we began selling through mass retailers and made a strong start, with products selling out day after day when sales staff were dispatched to the relevant retailer. Although e-commerce sales have been slow to get off the ground, we will seek to increase sales by raising advertising spending and pursuing synergies with sales through the mass retailers mentioned above.」
Specific progress has been reported in measures to expand distribution of high-value-added products, cosmetics and other products, including the launch of sales through mass retailers and products selling out every day. The Company aims to expand e-commerce sales by increasing advertising. - FY2021-Q2AdvancedAnnual report
「At the same time, we will continue using social media and other advertising to promote cosmetics to customer segments that do not use eyelash extensions, while expanding sales channels by opening stores in mass retailers and e-commerce marketplaces.」
In addition to promoting cosmetics to customers who do not use eyelash extensions, specific measures have been presented to expand sales channels by opening outlets in mass retailers and e-commerce shopping malls. - FY2021-Q1RestatedAnnual report
「In selling products, we will promote cosmetics for at-home eyelash care to customer segments that do not use eyelash extensions, including customers who have eyelash perms and customers with natural eyelashes.」
The policy of expanding sales channels for high-value-added products, primarily cosmetics, continues in the form of promoting home-care products to customers who do not use eyelash extensions. - FY2020RestatedAnnual report
「With respect to product sales, we will seek to increase sales through overseas expansion.」
The policy of increasing sales through overseas expansion of products in the eyelash-care business has been reconfirmed. - FY2020-Q3RestatedAnnual report
「In addition, we pursued initiatives to increase awareness and expand sales channels by securing media exposure and exhibiting at trade shows, primarily for our own cosmetics and health foods, resulting in an increase in selling, general and administrative expenses for those initiatives.」
Initiatives to increase awareness and expand sales channels for the Company's own cosmetics and health foods through media exposure and trade-show participation are continuing. - FY2020-Q2RestatedAnnual report
「In addition, we pursued initiatives to increase awareness and expand sales channels by securing media exposure and exhibiting at trade shows, primarily for our own cosmetics and health foods,」
Initiatives to increase awareness and expand sales channels for the Company's own cosmetics and health foods through media exposure and trade-show participation are continuing. - FY2020-Q1AdvancedAnnual report
「In this business, we previously sold products such as eyelash extensions on a B2B basis. In addition, we have begun handling cosmetics, primarily basic skincare products, for B2C sales. Through these initiatives, we will seek to increase sales.」
A specific expansion of sales channels has been presented through the launch of B2C sales of cosmetics, primarily basic skincare products, in addition to the existing B2B sales. - FY2019First statedAnnual report
「With respect to products for sale, we will seek to expand high-value-added products using stem cells and other materials, as well as expand distribution of existing and high-value-added products.」
It was stated for the first time that, in the eyelash-care business, the Company would seek to expand high-value-added products using stem cells and other materials, along with distribution, including existing products.